Blog - Page 2175 of 5771

MondayJan 07, 2019 1:22 pm

BriaCell Therapeutics Corp. (OTCQB: BCTXF) (TSX.V: BCT) Advances Novel Formulation of Drug Candidate in Battle against Advanced Breast Cancer

Development of frozen formulation of Bria-IMT completed for on-demand shipment to clinical sites Novel formulation is easily transportable to distant locations, easy to use, safe and has improved potency; it accommodates higher patient volumes at reduced per-dose costs Promising novel immunotherapy technology provides hope to patients with advanced breast cancer Breast cancer remains the leading cancer diagnosed in women and the second-most common cancer overall Immuno-oncology focused biotechnology company, BriaCell Therapeutics Corp. (OTCQB: BCTXF) (TSX.V: BCT) recently announced the imminent clinical use of a novel, frozen formulation of Bria-IMT, the company’s lead cancer drug candidate targeting the unmet medical needs…

MondayJan 07, 2019 12:52 pm

Legislative Changes in the US Provide SinglePoint, Inc. (SING) with Rapid Growth Opportunities in 2019 and Beyond

As the 2018 Federal Farm Bill legalizes hemp across the U.S., SinglePoint prepares for rapid growth in 2019 The company is working on development programs and potential acquisitions in order to establish its leading industry position Through hemp legalization, the industry is expected to grow exponentially in the years to come, reaching a volume of $20 billion by 2022 Congressional approval of the 2018 Federal Farm Bill that removes hemp production from federal prohibition is expected to create amazing new opportunities for industry representatives in 2019 and beyond. SinglePoint, Inc. (OTCQB: SING) released an official statement underlining that the legislative…

MondayJan 07, 2019 12:31 pm

Icon Exploration Inc. (TSX.V: IEX.H) Set to Capture High Margins with Vertical Integration Strategy in Canadian Cannabis

Canadian cannabis market set for CAGR of 77.9 percent to 2021 Icon’s Vertical integration strategy could capture high margins Company will have operations in cultivation, extraction and retail The legalization of recreational cannabis in Canada has made analysts project rapid growth for the industry. Spending on adult-use marijuana (http://ibn.fm/BtVkp) is “estimated to reach over $3 billion in 2021, driving a CAGR of 77.9 percent from 2018-2021.” Eventually, Canada’s legal cannabis market will likely be comparable in size to the hard liquor or wine market. Growing organically, some sectors will be profitable (others, perhaps, less so), but telling which may not be…

MondayJan 07, 2019 12:03 pm

Sproutly Canada, Inc. (OTCQB: SRUTF) (CSE: SPR) (FRA: 38G) Building Cannabis-Infused Beverage Solutions with Leadership Depth

Consumer reports show growing tendency to reject smoke-inhaled substances such as cigarettes Sproutly Canada’s solution provides truly water-soluble cannabis product that mimics rapid onset, offset of smoked drug Cannabis-infused beverage market potential forecast between $900 million and $4.4 billion by 2024 As savvy cannabis investors look toward the market potential of the beverage-ization of their natural plant products, suppliers such as Sproutly Canada, Inc. (OTCQB: SRUTF) (CSE: SPR) (FRA: 38G) are strengthening their operations by adding more experienced executives, building their distribution networks and increasing their output capabilities. Sproutly Canada is focused on cultivating pharmaceutical-grade cannabis for the backbone of…

MondayJan 07, 2019 11:34 am

QualityStocksNewsBreaks – SinglePoint, Inc. (SING) Invests in TorusMed Inc. for Lab-Based Development of CBD Cell Cultures

Technology and investment company SinglePoint (OTCQB: SING) this morning announced its investment in TorusMed Inc. to develop cannabidiol (“CBD”) cell cultures from industrial hemp. According to the update, the ultimate goal of the project is the development of pharmaceutical grade CBD that is cultivated in lab settings, potentially changing the way industrial hemp and CBD are manufactured, reducing time, cost and resources while increasing consistency, safety and scalability. The project’s specific aim is to develop optimal protocols for mass CBD production from cell cultures of industrial hemp, which offers several advantages as compared to open-field farm cultivation including, but not…

MondayJan 07, 2019 11:30 am

Asset Acquisitions Grant New Potential to Payment Technology Developer Net Element, Inc. (NASDAQ: NETE)

Net Element transaction with Argus Merchant Services and Treasury Payments leads to expectations of added gross profits in next four years E-commerce expected to command larger share of sales revenues than brick-and-mortar retail by 2022 Net Element technologies adaptable to wide variety of mobile and online business needs World finance technology innovator Net Element, Inc. (NASDAQ: NETE) is building its own capital potential as well as that of its customers, announcing recently that it has acquired cash flow assets that are expected to generate well over $4 million in gross profits over the next four years and continued profits thereafter.…

MondayJan 07, 2019 10:57 am

Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) is “One to Watch”

100 percent ownership of the Cyclops Nickel-Cobalt Project in strategic location along northern coast of Indonesia Production/mining permits issued along with environmental (AMDAL) permit issued Significant, shallow mineralization at project site with a historical* estimate of 37Mt @ 0.11% Co and 1.31%Ni at 0.8% Ni cut-off grade Significant potential for expansion as mineralization is open at depth and on-strike Estimate based on over 856 shallow drill holes and 26 test pits Historical (non-compliant to 43-101 standards) high-grade drill intercepts of 8m @ 0.18% Co; 13m @ 0.15% Co; and 10m @ 0.19% Co Strategically located near China, the world’s largest…

MondayJan 07, 2019 10:39 am

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Eagerly-Anticipated Commercial Launch of Biopharmaceuticals Contract Services Business

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of high pressure-based instruments, consumables, and related services for the global life sciences industry, this morning announced the commercial launch of its Biopharmaceuticals Contract Services Business. The eagerly-anticipated launch follows PBIO’s December 2017 acquisition of the assets of BaroFold, Inc., including patents, equipment, and other intellectual property relating to its unique, high pressure-based protein disaggregation and refolding platform. PBIO expects the technology platform to offer substantial improvement in the quality and costs of manufacturing protein therapeutics. “We are excited to announce the launch of our Biopharmaceutical Contract Services Business…

MondayJan 07, 2019 9:57 am

QualityStocksNewsBreaks – CytoDyn Inc. (CYDY) Names Richard G. Pestell, M.D., Ph.D. as Board Vice Chairman, Expanding Leadership Role in Advancement of Company Initiatives

Biotechnology company CytoDyn (OTCQB: CYDY) today announced the election of its Chief Medical Officer and Director Richard G. Pestell, M.D., Ph.D., M.B.A., F.A.C.P., F.R.A.C.P. to the additional position of vice chairman of the board of directors. In this added role Pestell, an internationally renowned clinician and cancer researcher and defining force in CCR5 antagonist research, will advance and accelerate CYDY’s initiatives in seeking non-dilutive licensing opportunities in cancer and immunology. “We are honored to have Dr. Pestell serve as our Vice Chairman,” CytoDyn President and Chief Executive Officer Nader Pourhassan stated in the news release. “He is a world renowned…

MondayJan 07, 2019 9:47 am

QualityStocksNewsBreaks – Foresight Autonomous Holdings Ltd.’s (NASDAQ: FRSX) (TASE: FRSX) Eye-Net Mobile Collaborates with Leading Israeli Cellular Provider in Successful Initial Integration

Automotive technology innovator Foresight Autonomous Holdings (NASDAQ: FRSX) (TASE: FRSX) this morning announced that its wholly owned subsidiary Eye-Net Mobile Ltd. has successfully installed its Eye-Net application’s communication layer on the data center of a leading Israeli cellular provider. A V2X cellular-based accident prevention solution, Eye-Net is designed to provide real-time pre-collision alerts to pedestrians and vehicles through smartphones and reliance on existing cellular networks. Collaboration with the cellular provider and leveraging its technological expertise and engineering design assistance may improve Eye-Net’s efficiency, allowing for more accurate alerts, most significant with the application’s deployment across a large number of mobile…

Site Search

Company Search